Načítá se...
Risk of using hydroxychloroquine as a treatment of COVID-19
The emerging COVID-19 pandemic poses a threat to the global health care system. Given the lack of antiviral therapies or vaccines for the disease, the antimalarial drug hydroxychloroquine (HCQ) obtained much attention as a treatment for COVID-19. However, there are limited and uncertain clinical dat...
Uloženo v:
| Vydáno v: | Int J Risk Saf Med |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
IOS Press
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7504983/ https://ncbi.nlm.nih.gov/pubmed/32474476 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JRS-200024 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|